Bionow | News

Bionow’s inaugural 2024 Neuroscience conference showcases key developments acr...

Jul 18th 2024

The first ever Neuroscience conference, hosted in Sheffield, proved to be a great success with 115 delegates and eight exhibitors collaborating and exploring the current challenges and oppor...

£2.1m award to develop eye cell ‘bandage’

Jun 28th 2024

A team of vision researchers from the University of Liverpool have received £2.1m to develop a contact lens that can repair eye damage.

Blueberry Therapeutics Meets Primary and Secondary Endpoints in Phase 2b Trial i...

Nov 22nd 2023

Blueberry Therapeutics Limited (“Blueberry” or “the Company”), a pharmaceutical company focused on developing innovative, topical nanomedicines to treat dermatological conditions, an...

First patient dosed in Phase 1 Trial

Oct 23rd 2023

Iksuda Therapeutics announces first patient dosed in Phase 1 trial of IKS014 in patients with advanced solid tumours that express HER2

PharmaKure announces study success for novel blood test to identify biomarkers i...

Oct 17th 2023

Study confirms ALZmetrixTM whole blood test can detect people at high risk of developing full Alzheimer’s Disease

Northern Gritstone invests in Pencil Biosciences, developer of novel gene editin...

Oct 3rd 2023

Pencil Biosciences is developing a fully synthetic gene modulation and editing platform that will have impact across a wide range of applications, including new therapeutic options for patie...

University secures £2.66m to develop personalised cancer treatment

Sep 15th 2023

University of Liverpool researchers have secured £2.66m Medical Research Council funding to clinically test a novel immunotherapeutic strategy for non-small cell lung cancer – one of the ...

Sight-saving MedTech sleep mask could save the NHS multimillions

Oct 28th 2022

MedTech company PolyPhotonix has had its innovative diabetes sleep mask adopted in the NHS for the first time.

New report finds personalised testing of common medicines must be offered throug...

Mar 30th 2022

The report was produced by a working party chaired by a University of Liverpool academic, Professor Sir Munir Pirmohamed

New study into cancer cells to help improve chemotherapy effectiveness

Mar 2nd 2022

A new Liverpool led study, published in Gut, has identified how immune cells in the body can promote the regrowth of cancer cells after chemotherapy withdrawal. These findings will help impr...

Liverpool recruits first UK patient for personalised ‘therapeutic cancer vacci...

Jul 1st 2021

Researchers in Liverpool have begun recruiting patients to a ‘first-in-human’ clinical trial of personalised ‘vaccines’ that aim to reduce the risk of head and neck cancers – which...

Infex appoints Lonza to manufacture new lung infection drug

May 14th 2021

Infex Therapeutics has awarded a £1m contract to Lonza to help progress its RESP-X program, a novel therapy which targets serious recurrent respiratory infections in patients with damaged l...

News